News
AI and mobile integration drive surge in smart inhaler adoptions
AI and mobile integration drive surge in smart inhaler adoptions
Rising need for personalised and remote healthcare also drives adoption.
$110m funding boost to support Australians with chronic conditions
Chronic conditions cause 90% of deaths and affect most Australians.
Structural heart devices market to reach $2.93b by 2032
Asia Pacific is the fastest-growing region with a 10.0% CAGR.
Rising CKD cases and advanced biomarkers fuel $4.8b market growth
Market growth is expected to continue through 2034.
Peripheral vascular devices market to reach $15.5b by 2032
Increasing prevalence of PAD and lifestyle-related vascular disorders drives demand.
Global prescription drugs market to reach $2.26t by 2034
The Asia Pacific region is projected to register the fastest growth rate.
Rising cases, advanced diagnostics drive biliary tract cancer market growth across 7MM
Increasing cases were driven by aging populations and liver diseases.
IHH Healthcare FY2025 net profit falls 21% to $682.67m
The decrease is due to unrealised currency translation losses from a stronger ringgit.
Sunway Healthcare targets $4.34b market cap with Malaysia IPO
Proceeds from the listing will partially fund its expansion.
Automation, continuous manufacturing drive global pharmaceutical equipment demand
It is also driven by chronic diseases and biologics production.
Tam Anh invests $77m in proton therapy system
Deal signed during Vietnam-U.S. Comprehensive Strategic Partnership visit.
Aging population drives demand for durable medical equipment market
Telehealth, 3D printing, and customisation are amongst the key trends.
Hong Kong outlines ‘One plus Three’ model for life and health tech R&D
A headquarters for the Life and Health Technology Research Institutes will be set up.
iX Biopharma secures $52.8m US contract for pain reliever trials
The funding will be allocated for the late-stage development of Wafermine.
$85M funding to to boost health research, mRNA innovation in Australia
It targets serious health conditions with limited treatment options.
Infectious diseases, fast diagnostics drive clinical microbiology market
Asia-Pacific will see the fastest growth.
SLE, lupus nephritis market to more than double by 2034
It will be driven by nine new pipeline therapies targeting disease modification
Most Read
1. Southeast Asia faces uneven urology access as demand outpaces specialists 2. IHH Healthcare core profit up 3% in 2025 as revenue hits $6.6b 3. HKU develop RNA 'cut-and-patch' tool for treating neurodegenerative diseases 4. SNUH installs ‘smart hearing loop’ system for hearing-impaired patients 5. Seoul hospital, Harvard replace static AI testing with hospital simulatorResource Center
Read Here
Advertise
Sign Up
Event News
It will feature forums, demos, and business matching activities.
Commentary
How the healthcare ecosystem is responding to change the trajectory of myopia
Technology’s role in making Indian healthcare truly patient-centric